98%
921
2 minutes
20
The global population breathes unsafe levels of pollutants. In recent years, electronic cigarettes (e-cigs) have become a significant source of particulate matter (PM), which causes injurious effects across organ systems. E-cig users and bystanders are exposed to concentrated aerosols, commonly called vapor, that we now know can have harmful long-term consequences due to PM and chemicals contained within. E-cigs are diverse in design, and e-liquids vary dramatically, making it difficult to draw broad conclusions from studies of different devices, brands, and flavors. With the rise in popularity of e-cigs, it is important to define the health effects across the body. In this comprehensive review, we dissect and summarize the known organ-specific effects of e-cigs, including underlying molecular mechanisms. Notably, e-cig aerosols broadly cause increased cytokine release and oxidative stress, which are associated with a heightened risk of organ dysfunction. We also highlight ways to minimize harmful e-cig constituents to develop safer products.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1146/annurev-pharmtox-062124-022856 | DOI Listing |
Naunyn Schmiedebergs Arch Pharmacol
September 2025
Laboratory of Mathematical Modeling of Physical and Chemical Processes in Multiphase Media, Department of Theoretical and Mathematical Physics, Ural Federal University, Lenin Ave., 51, Yekaterinburg, 620000, Russian Federation.
Industrial emissions of cadmium, which is used in various industries, and formation of cadmium nanoparticles during high-temperature technological processes aggravate the problem of chemical pollution. Insufficient understanding of the toxic impact of cadmium nanoparticles, coupled with the serious multisystem toxicity of this metal, necessitate expansion of knowledge about their potential toxic effects. We assessed the response of female outbred albino rats to subchronic exposure to cadmium oxide nanoparticles (CdO NPs) administered intranasally at the concentration of 0.
View Article and Find Full Text PDFClin Toxicol (Phila)
September 2025
Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, CO, USA.
Introduction: The clinical presentations associated with spp. (true morel) and spp. (false morel) mushroom ingestions are incompletely characterized.
View Article and Find Full Text PDFComp Biochem Physiol C Toxicol Pharmacol
December 2025
Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, China. Electronic address:
The element lead (Pb) exhibits significant toxicity throughout aquatic habitats. Crustaceans sit at the top of the aquatic food chain and therefore are especially susceptible to Pb-associated toxicity. Nevertheless, there is limited information on the crustaceans exposed to Pb.
View Article and Find Full Text PDFVaccines (Basel)
August 2025
Cerebrovascular and Neurocognitive Disorders Research Group, Department of Morphology & Physiology, Institute of Translational Medicine, HUN-REN SE, Semmelweis University, 1094 Budapest, Hungary.
mRNA-LNP-based COVID-19 vaccines, namely Pfizer-BioNTech's Comirnaty and Moderna's Spikevax, were successfully deployed to help control the SARS-CoV-2 pandemic, and their updated formulations continue to be recommended, albeit only for high-risk populations. One widely discussed aspect of these vaccines is their uniquely broad spectrum and increased incidence of adverse events (AEs), collectively referred to as post-vaccination syndrome (PVS). Although the reported PVS rate is low, the high number of administered doses among healthy individuals has resulted in a substantial number of reported vaccine-related injuries.
View Article and Find Full Text PDFAnn Neurol
August 2025
Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA.
Objective: Myotonic dystrophy type 1 (DM1) is a highly variable, multisystemic genetic disorder caused by a CTG repeat expansion in the 3' untranslated region of DMPK. Toxicity is exerted by repeat-containing DMPK transcripts that sequester muscleblind-like (MBNL) proteins and lead to deleterious yet predictable changes in alternative splicing. To contend with high phenotypic and molecular variability that complicate application of viral-based therapies, we develop and test a DM1-responsive genetic element to control viral-based therapeutic output.
View Article and Find Full Text PDF